You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 49 No. 12, December 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (54)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neurologic Manifestations of Progressive Systemic Sclerosis

Lea Averbuch-Heller, MD; Israel Steiner, MD; Oded Abramsky, MD, PhD

Arch Neurol. 1992;49(12):1292-1295.


Abstract

• Neurologic involvement in progressive systemic sclerosis is considered uncommon. We retrospectively examined the prevalence and nature of neurologic complications in 50 patients with progressive systemic sclerosis. In 20 (40%), neurologic abnormalities were detected, with a total of 28 neurologic manifestations. All levels of the central and peripheral nervous system were affected: muscle (22%), peripheral nerve (18%), spinal cord (8%), and brain (6%). Of note were the presence of myelopathy in four patients and inclusion-body myositis in two. In 10 patients (20%), no definable cause of the neurologic dysfunction could be identified, apart from progressive systemic sclerosis. Thus, neurologic presentations of progressive systemic sclerosis are much more common than previously reported and may be due to direct involvement of the nervous system by a primary pathologic process in a significant number of patients.



Author Affiliations

From the Department of Neurology, Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem, Israel.


Footnotes

Accepted for publication June 25, 1992.

Reprint requests to Department of Neurology, Hadassah University Hospital, PO Box 12000, IL-91120, Jerusalem, Israel (Dr Averbuch-Heller).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Macrovascular disease and atherosclerosis in SSc
Hettema et al.
Rheumatology (Oxford) 2008;47:578-583.
ABSTRACT | FULL TEXT  

Cerebellar atrophy in systemic sclerosis
Pinheiro et al.
JRSM 2004;97:537-538.
FULL TEXT  

Transverse Myelitis in Systemic Sclerosis
Torabi et al.
Arch Neurol 2004;61:126-128.
ABSTRACT | FULL TEXT  

Multiple sclerosis in the course of systemic sclerosis
Chroni et al.
Ann Rheum Dis 2002;61:188-188.
FULL TEXT  

Evidence of cerebral hypoperfusion in scleroderma patients
Cutolo et al.
Rheumatology (Oxford) 2000;39:1366-1373.
ABSTRACT | FULL TEXT  

Intracerebral Calcification in Systemic Sclerosis
Heron et al.
Stroke 1999;30:2183-2185.
ABSTRACT | FULL TEXT  

Brain Involvement in Scleroderma : Two Autopsy Cases
Heron et al.
Stroke 1998;29:719-721.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.